Form 8-K - Current report:
SEC Accession No. 0001641172-25-002396
Filing Date
2025-04-02
Accepted
2025-04-02 16:30:49
Documents
14
Period of Report
2025-04-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37602
2 ex99-1.htm EX-99.1 18342
  Complete submission text file 0001641172-25-002396.txt   235210

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE exoz-20250402.xsd EX-101.SCH 3015
4 XBRL LABEL FILE exoz-20250402_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE exoz-20250402_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3767
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42204 | Film No.: 25805226
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)